CAS: 1782970-28-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PTC-028 REF: IN-DA01FS6RCAS: 1782970-28-8 | 99% | To inquire | Thu 12 Dec 24 |
 | PTC-028 REF: TM-T16680CAS: 1782970-28-8 | 97.61% | 45.00 €~1,411.00 € | Thu 19 Dec 24 |
 | PTC 028 REF: 3D-BP168106CAS: 1782970-28-8 | Min. 95% | To inquire | Thu 23 Jan 25 |
PTC-028
CAS:1782970-28-8
PTC-028 selectively suppresses cancer cells whereas normal cells remain unaffected.
Formula:
C19H12F5N5
Purity:
97.61%
Color and Shape:
Solid
Molecular weight:
405.32
Ref: TM-T16680
| 1mg | 45.00 € | ||
| 2mg | 59.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 143.00 € | ||
| 25mg | 279.00 € | ||
| 50mg | 463.00 € | ||
| 100mg | 678.00 € | ||
| 500mg | 1,411.00 € | ||
| 1mL*10mM (DMSO) | 106.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
PTC 028
CAS:1782970-28-8
Lowers BMI-1 expression via post-translational modification; anti-cancer agent
Formula:
C19H12F5N5
Purity:
Min. 95%
Molecular weight:
405.32 g/mol
Ref: 3D-BP168106
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 23 Jan 2025
